Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GI

Decision Tree Algorithm for Diagnosing Incidental Gallbladder Uptake on FDG PET/CT

Randy Yeh, Ryan Reddy, Audrey Mauguen and Murad Abusamra
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1191;
Randy Yeh
1Memorial Sloan Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Reddy
1Memorial Sloan Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Mauguen
1Memorial Sloan Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murad Abusamra
1Memorial Sloan Kettering Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P1191

Introduction: Incidental gallbladder uptake is not an infrequent finding on oncologic FDG PET/CT. It can be challenging for the interpreting physician to determine a diagnosis and decide whether to recommend further imaging. While there are case reports describing false positive findings in the gallbladder on FDG PET, such as adenomyomatosis, no study has systematically evaluated incidental gallladder uptake and its causes. The aim of our study is to evaluate the causes of gallbadder uptake and develop a decision tree algorithm to use in routine clinical practice.

Methods: A retrospective study was conducted of all FDG PET/CT scans performed over 5 years (2014-2019) with gallbladder PET findings in the report impression. Patients with primary gallbladder cancer and CT only findings (i.e. cholelithiasis) were excluded. PET/CT images were retrospectively reviewed and the gallbladder FDG uptake morphology, location within wall or lumen, anatomic location, and SUVmax were assessed. The suspected diagnosis of gallbladder uptake was determined through review of prior and follow-up imaging and classified as either benign (i.e. adenomyomatosis) or malignant conditions. Logistic regression was performed for correct classification of gallbladder uptake into benign vs. malignant conditions. Classification and regression tree (CART) modeling was performed with minimum bucket=1, maximum depth =3, and cross-validation.

Results: A total of 98 patients were included in the analysis. PET uptake was due to a benign gallbladder condition in 87% of patients (n=62/98) and malignancy in 13% (n=13/98). PET uptake morphology, location within wall or lumen, and SUVmax were statistically significant on univariable analysis (all p<0.05). Only SUVmax remained significant on multivariable analysis, with higher SUVmax associated with risk of malignancy OR =1.33 [1.10 - 1.66 95% CI], p=0.003. ROC curve analysis demonstrated an optimal cutoff SUVmax of 4.7, with AUC=0.88, sensitivity 100%, and specificity 67% (Fig. 1). A decision tree algorithm was created using CART modeling, with root node error = 0.133 and 88.8% prediction accuracy in cross-validation (Fig. 2). In this tree, the first step is to stratify uptake based on SUVmax (<6.1 or >6.1), then location within wall, lumen, or both, and then uptake morphology. On the left side of the tree, all patients have SUXmax <6.1 and if PET uptake is in the wall or lumen, then it is due to a benign condition. If PET uptake is found in the both wall and lumen, then the diagnosis depends on segmental morphology. On the right side of the tree, all patients have SUVmax >6.1 and if PET uptake is in the wall, then it is benign, whereas if it is in the lumen or both, then it is malignant.

Conclusions: The majority of incidental gallbladder uptake on FDG PET/CT scans are due to benign gallbladder conditions. Higher SUVmax is associated with higher odds of malignancy versus benign conditions. Our PET gallbladder uptake decision algorithm can be easily implemented to facilitate reader interpretation, improve diagnostic accuracy, and decide appropriate management.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Decision Tree Algorithm for Diagnosing Incidental Gallbladder Uptake on FDG PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Decision Tree Algorithm for Diagnosing Incidental Gallbladder Uptake on FDG PET/CT
Randy Yeh, Ryan Reddy, Audrey Mauguen, Murad Abusamra
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1191;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Decision Tree Algorithm for Diagnosing Incidental Gallbladder Uptake on FDG PET/CT
Randy Yeh, Ryan Reddy, Audrey Mauguen, Murad Abusamra
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1191;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Correlation of FDG and FPSG PET parameters with sarcopenia and overall survival in patients with pancreatic ductal adenocarcinoma
  • Oral administration of bevacizumab-800CW and cetuximab-800CW for the detection of early esophageal neoplastic lesions by quantitative fluorescence molecular endoscopy
  • Impact of [68Ga]-FAPI /[18F]FDG- dual tracer PET/CT imaging on radiotherapeutic management and target volume definition in esophageal cancer
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GI

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire